False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives
Επιτομή
Introduction: A novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was reported via nucleic acid identification in December, 2019. Accuracy of SARS-CoV-2 diagnostic assays has emerged as a major barrier to COVID-19 diagnosis, particularly in cases requiring urgent or emergent treatment. Areas covered: In this review, we explore the major reasons for false-positive and false-negative SARS-CoV-2 test results. How clinical characteristics, specific respiratory comorbidities and SARS-CoV-2 vaccination impact on existing diagnostic assays are highlighted. Different COVID-19 management algorithms based on each test and limitations are thoroughly presented. Expert opinion: The diagnostic accuracy and the capacity of every available assay, which need to be interpreted in the light of the background incidence of SARS-CoV-2 infection in the communities in which they are used, are essential in order to minimize the number of falsely tested cases. Automated testing platforms may enhance diagnostic accuracy by minimizing the potential for human error in assays’ performance. Prior immunization against SARS-CoV-2 impairs the utility of serologic testing of suspected COVID-19 cases. Future avenues of research to evaluate lung tissue innate immune responses hold promise as a target for research to optimize SARS-CoV-2 and future infections’ testing accuracy. © 2021 Informa UK Limited, trading as Taylor & Francis Group.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Factors associated with healthcare workers’ (HCWs) acceptance of COVID-19 vaccinations and indications of a role model towards population vaccinations from a cross-sectional survey in Greece, may 2021
Fotiadis K., Dadouli K., Avakian I., Bogogiannidou Z., Mouchtouri V.A., Gogosis K., Speletas M., Koureas M., Lagoudaki E., Kokkini S., Bolikas E., Diamantopoulos V., Tzimitreas A., Papadopoulos C., Farmaki E., Sofos A., Chini Μ., Tsolia M., Papaevangelou V., Ntzani E.E., Gikas A., Prezerakos P., Hadjichristodoulou C. (2021)A Knowledge, Attitudes and Practices (KAP) study was conducted at the end of May 2021 engaging 1456 healthcare workers (HCWs) from 20 hospitals throughout Greece. Acceptance of vaccination against coronavirus disease 2019 ... -
Effects of Different Drug Therapies and COVID-19 mRNA Vaccination on Semen Quality in a Man with Ankylosing Spondylitis: A Case Report
Chatzimeletiou K., Fleva A., Sioga A., Georgiou I., Nikolopoulos T.-T., Markopoulou M., Petrogiannis N., Anifandis G., Patrikiou A., Kolibianakis E., Giannakou A., Grimbizis G. (2022)Background and Objectives: Ankylosing spondylitis (AS) is a condition that affects 0.1% to 0.5% of the adult population. The aim of this case report was to investigate the possible effects of the drugs taken for treatment ... -
Immunogenicity after the first dose of the BNT162b2 mRNA Covid-19 vaccine: Real-world evidence from Greek healthcare workers
Kontopoulou K., Ainatzoglou A., Ifantidou A., Nakas C.T., Gkounti G., Adamopoulos V., Papadopoulos N., Papazisis G. (2021)Real-world data regarding the effectiveness, safety and immunogenicity of the Pfizer-BioNTech BNT162b2 mRNA vaccine are accumulating in the literature, suggesting that this vaccine generates high titres of S1-binding IgG ...